(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-09-09 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 44784930
Date | Daily Closing Price | Open | High | Low | Volume |
09 Tue Sep 2025 | 0.05 | 0.04 | 0.05 | 0.04 | 0.594 times |
08 Mon Sep 2025 | 0.04 | 0.04 | 0.05 | 0.04 | 0.642 times |
05 Fri Sep 2025 | 0.04 | 0.05 | 0.05 | 0.04 | 0.744 times |
04 Thu Sep 2025 | 0.05 | 0.05 | 0.05 | 0.05 | 0.653 times |
03 Wed Sep 2025 | 0.05 | 0.06 | 0.06 | 0.05 | 0.824 times |
02 Tue Sep 2025 | 0.06 | 0.06 | 0.06 | 0.06 | 0.58 times |
29 Fri Aug 2025 | 0.06 | 0.07 | 0.07 | 0.06 | 0.924 times |
29 Fri Aug 2025 | 0.06 | 0.07 | 0.07 | 0.06 | 0.93 times |
28 Thu Aug 2025 | 0.07 | 0.06 | 0.07 | 0.06 | 2.032 times |
27 Wed Aug 2025 | 0.06 | 0.06 | 0.06 | 0.06 | 2.199 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 0.1, but if it comes above 0.1, then a intra day buy could be more profitable.
If you take a sell trade below 0.1, then use 0.1 as stoploss and 0 as target. However if you take a buy trade in stock , then use 0.1 as stoploss and 0.06 as target.
Share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Target | 0.04 |
Downside Target | 0.05 |
Upside Target | 0.06 |
Upside Target | 0.07 |
Upside Target | 0.08 |
Upside Target | 0.09 |
Upside Target | 0.12 |
Upside Target | 0.23 |
Upside Target | 0.25 |
Upside Target | 0.31 |
Upside Target | 0.33 |
Upside Target | 0.36 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Intraday Target | 0.04 |
Downside Intraday Target | 0.04 |
Downside Intraday Target | 0.05 |
Upside Intraday Target | 0.06 |
Downside Intraday Target | 0.05 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Weekly Closing Price | Open | High | Low | Volume |
09 Tue Sep 2025 | 0.05 | 0.04 | 0.05 | 0.04 | 0.441 times |
05 Fri Sep 2025 | 0.04 | 0.06 | 0.06 | 0.04 | 3.032 times |
29 Fri Aug 2025 | 0.06 | 0.07 | 0.07 | 0.06 | 0.149 times |
29 Fri Aug 2025 | 0.06 | 0.06 | 0.07 | 0.06 | 0.437 times |
22 Fri Aug 2025 | 0.06 | 0.09 | 0.09 | 0.05 | 4.163 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Monthly Closing Price | Open | High | Low | Volume |
09 Tue Sep 2025 | 0.05 | 0.06 | 0.06 | 0.04 | 0.104 times |
29 Fri Aug 2025 | 0.06 | 0.09 | 0.12 | 0.05 | 6.14 times |
31 Thu Jul 2025 | 0.08 | 0.24 | 0.36 | 0.08 | 21.89 times |
30 Mon Jun 2025 | 0.24 | 0.30 | 0.31 | 0.23 | 0.392 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Adaptimmune Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.06 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Adaptimmune Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.06 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.